Cargando…
Network Pharmacology and Molecular Docking-Based Mechanism Study to Reveal Antihypertensive Effect of Gedan Jiangya Decoction
Primary hypertension is understood as a disease with diverse etiology, a complicated pathological mechanism, and progressive changes. Gedan Jiangya Decoction (GJD), with the patent publication number CN114246896A, was designed to treat primary hypertension. It contains six botanical drugs; however,...
Autores principales: | Liu, Hanxing, Mohammed, Shadi A. D., Lu, Fang, Chen, Pingping, Wang, Yu, Liu, Shumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423997/ https://www.ncbi.nlm.nih.gov/pubmed/36046450 http://dx.doi.org/10.1155/2022/3353464 |
Ejemplares similares
-
The Traditional Chinese Medicine Gedan Jiangya Decoction Alleviates Left Ventricular Hypertrophy via Suppressing the Ras/ERK1/2 Signaling Pathway
por: Mohammed, Shadi A. D., et al.
Publicado: (2022) -
Network Pharmacology Prediction and Pharmacological Verification Mechanism of Yeju Jiangya Decoction on Hypertension
por: Wang, Ting, et al.
Publicado: (2021) -
Antihypertensive, antioxidant, and renal protective impact of integrated GJD with captopril in spontaneously hypertensive rats
por: Mohammed, Shadi A. D., et al.
Publicado: (2023) -
The combination of molecular docking and network pharmacology reveals the molecular mechanism of Danggui Niantong decoction in treating gout
por: Liu, Yuan, et al.
Publicado: (2022) -
Network Pharmacology and Molecular Docking Analysis Reveal Insights into the Molecular Mechanism of Shengma-Gegen Decoction on Monkeypox
por: Dai, Liujiang, et al.
Publicado: (2022)